21st Century Cures Legislative Phase Continues
WASHINGTON, DC - After nearly a year of listening to patients, innovators, researchers, providers, and regulators, 21st Century Cures next week will take the next step in the legislative phase with a hearing, "Legislative Hearing on 21st Century Cures," on Thursday, April 30, 2015, at 10:00 a.m. in room 2123 of the Rayburn House Office Building. Subcommittee members will discuss a forthcoming bipartisan discussion draft of this highly anticipated legislation, the product of a yearlong listening session and bipartisan negotiations.
The committee has held eight hearings and issued several white papers in this initiative since its launch last year. Committee members, both in Washington, D.C., and across the country, have also hosted more than two-dozen roundtables to generate ideas for this initiative. Staff continues to work together around the clock as they have for the past several months and legislative text will be made available in the coming days.
Dr. Kathy Hudson, Deputy Director for Science, Outreach, and Policy at the National Institutes of Health, Dr. Janet Woodcock, Director of the Center for Drug Evaluation and Research at the Food and Drug Administration, and Dr. Jeff Shuren, Director of the Center for Devices and Radiological Health at the FDA will testify.
The Majority Memorandum, legislative text, and witness testimony will be available here as they are posted.